Commonwealth Consolidated Regulations

[Index] [Table] [Search] [Search this Regulation] [Notes] [Noteup] [Previous] [Next] [Download] [Help]

NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS 2017 - REG 83

Information that must not be taken into account

  (1)   This Subdivision is made for the purposes of subsection   99ADB(6A) of the Act.

  (2)   Section   84 prescribes information that must not be taken into account in determining the weighted average disclosed price of a listed brand of a pharmaceutical item (the WADP brand ) in respect of a data collection period.

  (3)   However, section   84 does not apply in relation to determining a weighted average disclosed price for the purposes of section   82.

  (4)   To avoid doubt, this Subdivision has effect:

  (a)   despite Subdivision B (weighted average disclosed price); and

  (b)   even if the information relates to the WADP brand.



AustLII: Copyright Policy | Disclaimers | Privacy Policy | Feedback